• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β信号通路:生物学功能与治疗靶点

Transforming Growth Factor-β Pathway: Biological Functions and Therapeutic Targets.

作者信息

Mekky Reham Hassan, Abo-El Fetoh Mohammed E, Faheem Safaa A, Radwan Abdullah F, Fawzy Mariam H, Mustafa Aya M, Said Mohamed A, Calina Daniela, Sharifi-Rad Javad, Cho William C

机构信息

Department of Pharmacognosy Faculty of Pharmacy Egyptian Russian University Badr City Cairo Egypt.

Department of Pharmacology and Toxicology Faculty of Pharmacy Egyptian Russian University Badr City Cairo Egypt.

出版信息

MedComm (2020). 2025 Jun 27;6(7):e70278. doi: 10.1002/mco2.70278. eCollection 2025 Jul.

DOI:10.1002/mco2.70278
PMID:40584407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12205216/
Abstract

Cancer progression is often driven by aberrant cell growth and genetic mutations, leading to metastasis. The transforming growth factor-beta (TGF-β) pathway, a key regulator of cellular growth and differentiation, exhibits dual roles in cancer by initially acting as a tumor suppressor and later promoting tumor progression and metastasis. Natural compounds, recognized for their diverse bioactivities and low toxicity, have shown potential in targeting cancer-related pathways, including TGF-β signaling. This review examines the therapeutic potential of natural products in modulating TGF-β signaling and their anticancer effects across various cancer types. We evaluated relevant preclinical and clinical studies assessing the impact of natural products on TGF-β modulation and cancer progression. Natural compounds from sources such as plants impact TGF-β signaling, influencing processes like cell proliferation, apoptosis, and angiogenesis. Key compounds reviewed include ginsenosides, halofuginone, and epigallocatechin gallate, demonstrating significant anticancer activity via TGF-β pathway modulation. These findings suggest natural products may serve as complementary therapies in cancer treatment by targeting TGF-β signaling, potentially improving patient outcomes. Continued research and clinical evaluation are necessary to integrate these compounds into conventional cancer therapies, aiming to offer safer, cost-effective options that enhance quality of life.

摘要

癌症进展通常由异常的细胞生长和基因突变驱动,从而导致转移。转化生长因子-β(TGF-β)通路是细胞生长和分化的关键调节因子,在癌症中发挥双重作用,最初作为肿瘤抑制因子,随后促进肿瘤进展和转移。天然化合物因其多样的生物活性和低毒性而闻名,已显示出针对包括TGF-β信号传导在内的癌症相关通路的潜力。本综述探讨了天然产物在调节TGF-β信号传导及其对各种癌症类型的抗癌作用方面的治疗潜力。我们评估了相关的临床前和临床研究,这些研究评估了天然产物对TGF-β调节和癌症进展的影响。来自植物等来源的天然化合物会影响TGF-β信号传导,影响细胞增殖、凋亡和血管生成等过程。综述的关键化合物包括人参皂苷、常山酮和表没食子儿没食子酸酯,它们通过调节TGF-β通路显示出显著的抗癌活性。这些发现表明,天然产物可能通过靶向TGF-β信号传导作为癌症治疗的辅助疗法,有可能改善患者的治疗效果。持续的研究和临床评估对于将这些化合物整合到传统癌症治疗中是必要的,旨在提供更安全、更具成本效益的选择,提高生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/28201d0aacf1/MCO2-6-e70278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/12c786fd1990/MCO2-6-e70278-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/3886ace97090/MCO2-6-e70278-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/6cf185766165/MCO2-6-e70278-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/4dfb203f6001/MCO2-6-e70278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/01e58d2a643f/MCO2-6-e70278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/3f32677750ea/MCO2-6-e70278-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/e40b350cfbe4/MCO2-6-e70278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/28201d0aacf1/MCO2-6-e70278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/12c786fd1990/MCO2-6-e70278-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/3886ace97090/MCO2-6-e70278-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/6cf185766165/MCO2-6-e70278-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/4dfb203f6001/MCO2-6-e70278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/01e58d2a643f/MCO2-6-e70278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/3f32677750ea/MCO2-6-e70278-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/e40b350cfbe4/MCO2-6-e70278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8d/12205216/28201d0aacf1/MCO2-6-e70278-g003.jpg

相似文献

1
Transforming Growth Factor-β Pathway: Biological Functions and Therapeutic Targets.转化生长因子-β信号通路:生物学功能与治疗靶点
MedComm (2020). 2025 Jun 27;6(7):e70278. doi: 10.1002/mco2.70278. eCollection 2025 Jul.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance.前列腺癌中的天然产物和长链非编码RNA:对病因学和治疗耐药性的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 18. doi: 10.1007/s00210-024-03736-x.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
10
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.

本文引用的文献

1
Y-27632 targeting ROCK1&2 modulates cell growth, fibrosis and epithelial-mesenchymal transition in hyperplastic prostate by inhibiting β-catenin pathway.靶向 ROCK1&2 的 Y-27632 通过抑制β-catenin 通路调节前列腺增生中的细胞生长、纤维化和上皮间质转化。
Mol Biomed. 2024 Oct 26;5(1):52. doi: 10.1186/s43556-024-00216-9.
2
Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications.基于长非编码 RNA 的癌症治疗的进展:靶向、递送和临床意义。
Med Oncol. 2024 Oct 20;41(11):292. doi: 10.1007/s12032-024-02534-y.
3
Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy.
喜树碱及其衍生物:在癌症治疗中的进展、机制和临床潜力。
Med Oncol. 2024 Oct 9;41(11):263. doi: 10.1007/s12032-024-02527-x.
4
P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators.P-糖蛋白(P-gp)驱动的癌症药物耐药性:生物学特征、非编码 RNA、药物和纳米调节剂。
Drug Discov Today. 2024 Nov;29(11):104161. doi: 10.1016/j.drudis.2024.104161. Epub 2024 Sep 7.
5
Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma.在使化疗(放疗)后的食管腺癌重新敏感化过程中对转化生长因子-β抑制反应的预测生物标志物。
Pharmacol Res. 2024 Sep;207:107315. doi: 10.1016/j.phrs.2024.107315. Epub 2024 Jul 24.
6
Exploring treatment options in cancer: Tumor treatment strategies.探索癌症的治疗选择:肿瘤治疗策略。
Signal Transduct Target Ther. 2024 Jul 17;9(1):175. doi: 10.1038/s41392-024-01856-7.
7
Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs.西维来司他,一种具有不良药代动力学的强效抗癌剂:其药理学特性的现有知识和开发新型药物的未来方向。
Biomed Pharmacother. 2024 Aug;177:117047. doi: 10.1016/j.biopha.2024.117047. Epub 2024 Jul 2.
8
TGF-β signaling: critical nexus of fibrogenesis and cancer.TGF-β 信号转导:纤维化与癌症的关键联系。
J Transl Med. 2024 Jun 26;22(1):594. doi: 10.1186/s12967-024-05411-4.
9
Current Evidence on Molecular Mechanisms of Andrographolide in Cancer.穿心莲内酯在癌症中分子机制的当前证据
Curr Med Chem. 2024 Jun 11. doi: 10.2174/0109298673295496240530100728.
10
Historical Perspective and Current Trends in Anticancer Drug Development.抗癌药物研发的历史回顾与当前趋势
Cancers (Basel). 2024 May 15;16(10):1878. doi: 10.3390/cancers16101878.